Which of These Statements Reflects a Provision Common to Both VHA Directive 1914 and VHA Directive 1915: Shared Requirements Explained

The provision common to both VHA Directive 1914 and VHA Directive 1915 is the requirement that every patient receiving care in a VHA emergency department or urgent care setting be screened for suicide risk using a standardized, validated tool, with documented follow-up for anyone who screens positive. Directive 1914 governs emergency department suicide risk screening and evaluation; Directive 1915 extends the same screening-and-documentation framework to urgent care settings. Both mandate universal screening, defined response pathways, and documented reassessment rather than leaving risk detection to clinician judgment alone.

The shared mechanism: universal screening with a defined response pathway

The most useful way to answer the keyword question is to understand why two separate directives would repeat the same core provision. The mechanism is a clinical cascade, and both directives describe the same cascade.

The first stage is universal screening. Every patient is asked a short set of validated questions, typically the Patient Health Questionnaire-2 (PHQ-2) followed by the PHQ-9 when the first two items flag risk, or a dedicated suicide-risk screen such as the Columbia-Suicide Severity Rating Scale screener. The point of a universal screen is that it removes individual clinician discretion from the decision to ask. A triage nurse asks everyone, so a patient who never volunteers distress still gets asked.

The second stage is a defined response to a positive screen. A positive result triggers a fuller evaluation, often a structured risk assessment, a safety plan, and a decision about disposition. The directives do not let a positive screen sit unaddressed; they require a documented next step.

The third stage is documentation. The screen result, the evaluation, and the disposition decision must be recorded in the medical record. This is what makes the provision auditable and what allows a facility to demonstrate compliance.

The fourth stage is reassessment. Risk is not static. A patient who screens negative at intake can become positive hours later. Both directives embed the expectation that risk is rechecked when clinical status changes.

The shared logic is that screening without a response pathway is theater. Both directives pair the screen with an obligation to act, which is why the provision is best described as a screen-and-respond requirement rather than a screening requirement alone.

Quantified context: why the screening burden is large

Suicide risk screening in acute care is not a marginal activity. Emergency departments in the Veterans Health Administration see millions of visits annually, and universal screening means the screen is applied at essentially every encounter. If a facility handles 50,000 emergency visits a year, universal screening produces 50,000 screening events, each of which generates a documented result and, for the subset that screens positive, a downstream evaluation.

The positive-screen rate matters for staffing. Published implementation experience with universal suicide-risk screening in emergency settings has generally found positive-screen rates in the range of roughly 5 to 15 percent, depending on the tool and the population. That range means a facility with 50,000 visits could generate 2,500 to 7,500 positive screens a year, each requiring a structured response.

The workflow implication is that the response pathway has to be staffed, not just written. A directive that mandates screening but does not resource the evaluation step creates a bottleneck. This is why both directives address the full cascade rather than only the questionnaire.

The time context also matters. Screening adds time to triage. A two-item screen takes under a minute, but a positive screen followed by a full assessment can add 20 to 60 minutes of clinician time. Facilities that implement universal screening without adjusting staffing tend to see the evaluation step compress in ways that undermine the directive's intent.

Edge cases that determine whether the provision works

The shared provision has boundaries that are easy to miss, and those boundaries are where compliance failures concentrate.

Patients who leave before screening. A patient who registers and leaves without being screened has not been screened. The directive's requirement attaches to the encounter, and a missed screen is a gap, not a neutral event. Facilities audit these gaps because they are the most common finding in internal reviews.

Patients who screen negative but disclose risk later. A negative screen is not a clearance. If a patient later discloses suicidal ideation, the response pathway re-engages. The screening result documents a moment, not a status.

Patients with communication barriers. A patient who cannot complete a verbal screen because of language, cognition, or acuity still requires a documented approach. The directives expect an alternative method, not a blank field.

Patients in boarding status. A patient held in the emergency department awaiting an inpatient bed remains in the screened population. Boarding is a high-risk period, and reassessment expectations are most relevant there.

Patients who decline. A declined screen is documented as declined. It is not the same as a negative screen, and the directives treat the distinction as meaningful.

Misconceptions about the shared provision

A common misconception is that the shared provision is simply "screen for suicide." That framing understates it. The shared provision is the screen plus the mandated response plus the documentation plus the reassessment. A facility that asks the questions but does not staff the response has implemented a fraction of the requirement.

A second misconception is that the two directives are redundant. They are not. Directive 1914 addresses the emergency department context; Directive 1915 addresses the urgent care context, which has different staffing, different length of stay, and different handoff patterns. The shared provision is deliberately repeated because the underlying clinical risk is the same even when the setting differs.

A third misconception is that a validated tool produces a verdict. Screening tools are calibrated to be sensitive rather than specific. A positive screen means "assess further," not "this patient is at high risk." A negative screen means "no current flag," not "no risk." Clinicians who treat the score as a diagnosis either over-trigger or under-trigger.

A fourth misconception is that documentation is bureaucracy. Documentation is the mechanism by which the response is verified. Without it, a facility cannot demonstrate that a positive screen led to an evaluation, which is precisely the failure the directives exist to prevent.

Practical actions for clinicians and facility leaders

For clinicians, the practical sequence is straightforward: screen every patient, act on every positive, document every step, and reassess when status changes. The failure modes are skipping the screen during high-volume periods and letting a positive screen wait for a clinician who is occupied elsewhere.

For facility leaders, the practical sequence is about resourcing and audit.

Verify that the screening tool in use is a validated instrument and that staff are trained on its administration. Staff the evaluation step explicitly, including after-hours coverage, so a positive screen has a named responder. Audit missed screens weekly and treat repeated misses as a workflow defect, not an individual failing. Confirm that the medical record captures screen result, evaluation, and disposition as discrete fields. Reassess the pathway when emergency department boarding times rise, because boarding concentrates risk. Review declined screens to confirm an alternative approach was documented.

Red-flag warnings worth treating as stop signals:

A positive screen with no documented next step is a compliance failure, not a documentation gap. A "negative" screen entered for a patient who was never asked is a data integrity problem. A screening tool changed without validation is a silent loss of comparability. An evaluation step assigned to no one is a pathway that will fail under load.

Comparison of the two directives at a glance

The table makes the shared provision visible. The rows that are identical across both directives are the provision the keyword question is asking about. The rows that differ are the setting-specific implementation guidance, which is why two directives exist rather than one.

Timeline of the screening cascade

The timeline shows why the provision is a cascade rather than a single event. The screening step is fast; the evaluation and disposition steps are where time and staffing concentrate. A facility that measures only the screening step will overstate its compliance.

Limitations and what the shared provision cannot do

The shared provision standardizes detection and response, but it cannot eliminate risk. A validated screen misses some patients, and a documented negative screen is not a guarantee. The directives improve the odds that a patient at risk is identified and routed to evaluation; they do not convert screening into prediction.

The directives also cannot substitute for clinical judgment. A patient who screens negative but whose presentation concerns the clinician should still be evaluated. The screen is a floor, not a ceiling.

Readers comparing the two directives should consult the current published versions directly, because directive numbering and content can be revised, and the summary here describes the stable structural provision rather than any specific revision date.

This article is general educational information about how VHA clinical directives are structured; it is not a diagnosis, treatment plan, or legal opinion, and it does not promise any clinical outcome. Clinicians should follow their facility's current directive text and local policy. If you or someone you know is in immediate danger or at risk of self-harm, contact local emergency services or a crisis line right away.